14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for AVCT.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 48.17 3.58 %
R2 47.40 1.94 %
R1 46.93 0.93 %
Current price: 46.50
Support S1 45.40 -2.36 %
S2 44.93 -3.37 %
S3 44.17 -5.02 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 54.50 17.20 %
R2 53.50 15.05 %
R1 50.75 9.14 %
Current price 46.50
Support S1 45.75 -1.61%
S2 44.60 -4.09%
S3 44.50 -4.30%

AVCT.L Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Avacta Group plc

Avacta Group plc Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow ra... AVCT.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT